X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
gic26 (18) 18
humans (18) 18
index medicus (18) 18
oncology (18) 18
male (16) 16
female (15) 15
original reports (15) 15
antineoplastic combined chemotherapy protocols - therapeutic use (14) 14
middle aged (14) 14
pancreatic neoplasms - drug therapy (14) 14
aged (13) 13
deoxycytidine - analogs & derivatives (13) 13
adult (12) 12
deoxycytidine - administration & dosage (11) 11
disease-free survival (9) 9
pancreatic neoplasms - pathology (9) 9
treatment outcome (9) 9
antineoplastic combined chemotherapy protocols - adverse effects (8) 8
adenocarcinoma - drug therapy (7) 7
kaplan-meier estimate (7) 7
pancreatic neoplasms - mortality (7) 7
therapy (7) 7
aged, 80 and over (6) 6
drug administration schedule (6) 6
deoxycytidine - adverse effects (5) 5
survival (5) 5
adenocarcinoma - mortality (4) 4
adenocarcinoma - pathology (4) 4
antimetabolites, antineoplastic - adverse effects (4) 4
combination (4) 4
gic25 (4) 4
united states (4) 4
adenocarcinoma (3) 3
antibodies, monoclonal - administration & dosage (3) 3
antibodies, monoclonal, humanized (3) 3
antimetabolites, antineoplastic - administration & dosage (3) 3
chemotherapy (3) 3
gic23 (3) 3
gic24 (3) 3
gic27 (3) 3
iii trial (3) 3
neoplasm staging (3) 3
neuroendocrine tumors - drug therapy (3) 3
pancreatic neoplasms - therapy (3) 3
quality-of-life (3) 3
survival analysis (3) 3
to15 (3) 3
adenocarcinoma - therapy (2) 2
angiogenesis (2) 2
animals (2) 2
antimetabolites, antineoplastic - therapeutic use (2) 2
asco special (2) 2
benefit (2) 2
bevacizumab (2) 2
bios3 (2) 2
cancer (2) 2
cetuximab (2) 2
chemotherapy, adjuvant (2) 2
clinical-trial (2) 2
deoxycytidine - therapeutic use (2) 2
ductal adenocarcinoma (2) 2
expression (2) 2
gdln1 (2) 2
gemcitabine (2) 2
gic5 (2) 2
islet-cell-carcinoma (2) 2
maximum tolerated dose (2) 2
mice (2) 2
neuroendocrine tumors - mortality (2) 2
nucleoside transporter 1 (2) 2
pancreatic neoplasms - radiotherapy (2) 2
phase-iii trial (2) 2
plus gemcitabine (2) 2
proportional hazards models (2) 2
prostate-cancer (2) 2
psc13 (2) 2
quality of life (2) 2
radiotherapy, adjuvant (2) 2
risk assessment (2) 2
sirolimus - administration & dosage (2) 2
sirolimus - adverse effects (2) 2
sirolimus - analogs & derivatives (2) 2
time factors (2) 2
1st-line therapy (1) 1
1st-line treatment (1) 1
30-minute infusion (1) 1
5-fluorouracil (1) 1
adenocarcinoma - diet therapy (1) 1
adenocarcinoma - genetics (1) 1
adenocarcinoma - psychology (1) 1
adenocarcinoma - radiotherapy (1) 1
adenocarcinoma - secondary (1) 1
administration, oral (1) 1
advanced solid tumors (1) 1
advanced thyroid-cancer (1) 1
albumin-bound paclitaxel (1) 1
albumins - administration & dosage (1) 1
albumins - therapeutic use (1) 1
alternative medicine (1) 1
anilides - pharmacology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2015, Volume 33, Issue 36, pp. 4284 - 4292
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2010, Volume 28, Issue 1, pp. 69 - 76
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2009, Volume 27, Issue 5, pp. 812 - 826
Nearly 40 years ago, President Richard Nixon signed the National Cancer Act, mobilizing the country's resources to make the "conquest of cancer a national... 
TRIAL | STAGE BREAST-CANCER | WOMEN | MELANOMA | ONCOLOGY | ADVANCED THYROID-CANCER | PROSTATE-CANCER | LETROZOLE | PHASE-II | FINASTERIDE | SORAFENIB | United States | Humans | Central Nervous System Neoplasms - therapy | Male | Lung Neoplasms - therapy | Gastrointestinal Neoplasms - therapy | Research | Sarcoma - therapy | Breast Neoplasms - therapy | Urogenital Neoplasms - therapy | Genital Neoplasms, Female - therapy | Medical Oncology - trends | Financing, Government - trends | Female | Child | Bone2 | Bone1 | To19 | To18 | To17 | Asco Special | To16 | Dxst | To25 | To24 | To23 | To22 | To21 | To20 | Sarc8 | Sarc7 | Dxst3 | Hsr1 | Sarc6 | Hsr2 | Sarc5 | Dxst1 | Sarc4 | Dxst2 | Thor3 | Thor4 | Thor5 | Thor6 | Psc14 | Psc13 | Thor7 | Thor8 | Thor9 | Neur6 | Neur4 | Neur5 | Neur3 | Gic20 | Pedi2 | Pedi3 | Gic2 | Gic19 | Gic18 | Gic4 | Gic3 | Thor11 | Gic6 | Gic5 | Gic11 | Gic9 | Gic10 | Gic13 | Gic12 | Guc3 | Guc4 | Gic17 | Gic16 | Guc2 | Gync10 | Gync11 | Gic31 | Gic30 | Gync16 | Gync17 | Gync18 | Gync19 | Gync12 | Sarc14 | Gync13 | Sarc15 | Sarc12 | Sarc13 | Pedi10 | Gic24 | Gic23 | Gic26 | Gic25 | Gic27 | Hema7 | Gync20 | Hema8 | Hema5 | Hema6 | Gic40 | Gdln1 | Hema19 | Hema15 | Hema14 | Hema13 | Hema12 | Hema11 | Gic33 | To15 | Gic32 | To14 | Gic34 | Gic37 | Gic39 | Gic38 | Guc5 | Guc6 | Guc18 | Guc17 | Guc16 | Guc9 | Guc13 | Guc12 | Guc11 | Gync2 | Guc10 | Gync4 | Hema24 | Gync3 | Hema23 | Gync6 | Hema22 | Gync5 | Hema21 | Hema20 | Bc4 | Bc3 | Gync9 | Bc6 | Hnc3 | Hnc12 | Bc5 | Hnc4 | Hnc13 | Hnc10 | Hnc2 | Hnc11 | Hnc5 | Hnc6 | Hnc9
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2009, Volume 27, Issue 33, pp. 5506 - 5512
Journal Article